Filana Therapeutics, Inc.
FLNA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001069530
In the last 90 days, Filana Therapeutics, Inc. insiders filed 2 open-market purchases and 0 sales; 78 institutions reported holding it in 13F filings for Q3 2026, worth $8.54M in total; no superinvestor holds it.
Key figures
- Market capClose on Nov 18, 2026
- $27.4M
- Insider buysLast 90 days, $356.3K in total
- 2
- Insider sellsOpen market, last 90 days
- 0
- 13F holdersQ3 2026, −5 vs. previous quarter
- 78
- 13F valueReported value at the end of Q3 2026
- $8.54M
- Superinvestors holdingAt the end of Q3 2026
- 0
Price chart
Financials
See financial statementsFrom SEC filings, in USD.
- Revenue, FY2025
- –
- No comparable prior period
- Net income, FY2025
- -$91.0M
- No comparable prior period
- Free cash flow, FY2025
- -$32.8M
- No comparable prior period
- Revenue, Q3 FY2026
- –
- No comparable prior period
Short interest
See short dataFrom FINRA, settlement date Oct 30, 2026.
- Short interest
- 5.68M
- Shares sold short
- Change
- +76.5K
- +1.4% vs. previous
- Days to cover
- 20.60
- At average daily volume
Superinvestors holding FLNA, Q3 2026
Go to the superinvestors tabNo superinvestor reported holding FLNA at the end of Q3 2026.
Latest insider trades
See all insider tradesOpen-market purchases and sales by Filana Therapeutics, Inc. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Oct 1, 2026 (view filing)7:57 AM ET | Sep 29-30 | 2 days | Barry RichardPresident & CEO | PPurchase | +306.8K | $0.9065 | +$278.1K | +29.8%1.34M after | 2 lots |
| Sep 30, 2026 (view filing)4:03 PM ET | Sep 28 | 2 days | Barry RichardPresident & CEO | PPurchase | +93.1K | $0.84 | +$78.2K | +9.9%1.03M after | |
| Nov 25, 2025 (view filing) | Nov 24 | 1 day | Anderson Robert Eugene JrDirector | PPurchase | +8.60K | $2.90 | +$24.9K | New position8.60K after | |
| Nov 24, 2025 (view filing) | Nov 20 | 4 days | Barry RichardPresident & CEO | PPurchase | +150.0K | $2.76 | +$414.0K | +19.0%938.1K after | |
| Nov 20, 2025 (view filing) | Nov 19 | 1 day | Barry RichardPresident & CEO | PPurchase | +73.4K | $2.75 | +$201.8K | +10.3%788.1K after | |
| Oct 2, 2025 (view filing) | Sep 30 | 2 days | Cook Robert ChristopherChief Operating & Legal Office | PPurchase | +13.7K | $2.91 | +$39.9K | New position13.7K after | |
| Sep 23, 2025 (view filing) | Sep 22 | 1 day | Barry RichardPresident & CEO | PPurchase | +7.17K | $2.28 | +$16.4K | +1.0%714.7K after | |
| Sep 22, 2025 (view filing) | Sep 18-19 | 4 days | Barry RichardPresident & CEO | PPurchase | +237.9K | $2.25 | +$534.7K | +50.7%707.5K after | 4 lots |
| Dec 3, 2024 (view filing) | Nov 29 | 4 days | Kupiec James WilliamChief Medical Officer | SSale | −4.00K | $3.87 | −$15.5K | −100.0%0 after | |
| Dec 3, 2024 (view filing) | Nov 29 | 4 days | Schoen EricChief Financial Officer | SSale | −2.00K | $3.82 | −$7.64K | −100.0%0 after |
Top 10 13F holders, Q3 2026
See all 78 holdersThe largest institutional positions in Filana Therapeutics, Inc. at the end of Q3 2026; share changes are against Q2 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Capital Management LLC | 1,929,726 | $1.71M | 0.00% | −45,255−2.3% | Reduced |
| BlackRock, Inc. | 1,446,715 | $1.28M | 0.00% | −6,846−0.5% | Reduced |
| Marshall Wace, LLP | 1,161,405 | $1.03M | 0.00% | −436,143−27.3% | Reduced |
| Geode Capital Management, LLC | 612,195 | $542.6K | 0.00% | −3,315−0.5% | Reduced |
| GMT Capital Corp | 450,100 | $398.8K | 0.02% | 00.0% | Unchanged |
| Gsa Capital Partners LLP | 435,661 | $386.0K | 0.02% | +166,251+61.7% | Added |
| Two Sigma Investments, LP | 423,400 | $375.1K | 0.00% | −1,287,958−75.3% | Reduced |
| Squarepoint Ops LLC | 375,992 | $333.1K | 0.00% | +57,612+18.1% | Added |
| Acadian Asset Management LLC | 317,177 | $280.0K | 0.00% | +22,118+7.5% | Added |
| Vanguard Fiduciary Trust Co | 315,889 | $279.9K | 0.00% | 00.0% | Unchanged |
Politician trades
All politician trades in FLNA1 member of Congress reported 5 trades in Filana Therapeutics, Inc. since 2020. Newest filings:
| Filed | Politician | Type | Amount |
|---|---|---|---|
| Jan 20, 2023 | Chris Jacobs House · NY | Buy | $1K-$15K |
| Dec 12, 2022 | Chris Jacobs House · NY | Sell | $1K-$15K |
| Nov 16, 2022 | Chris Jacobs House · NY | Buy | $1K-$15K |
| Sep 9, 2022 | Chris Jacobs House · NY | Sell | $1K-$15K |
| Jul 28, 2022 | Chris Jacobs House · NY | Buy | $15K-$50K |

House · NY · Jan 20, 2023
Buy$1K-$15K

House · NY · Dec 12, 2022
Sell$1K-$15K

House · NY · Nov 16, 2022
Buy$1K-$15K

House · NY · Sep 9, 2022
Sell$1K-$15K

House · NY · Jul 28, 2022
Buy$15K-$50K